International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The aim of the iSPOT-A study is to:
1. identify brain, genetic and cognitive markers of Attention Deficit/Hyperactivity
Disorder, and
2. identify brain, genetic and cognitive markers that predict treatment response to
short-acting methylphenidate in children and adolescents diagnosed with Attention
Deficit/Hyperactivity Disorder.